what is glp-1 agonist receptor agonists for individualized treatment of type 2 diabetes mellitus GLP-1 Receptor Agonists as Treatments

Metformin-induced glucagon-like peptide-1 secretion contributes to the actions of metformin in type 2 diabetes

DPP-4 inhibitors lack significant clinical benefits over newer anti-diabetic agents (i.e., GLP-1 agonists and SGLT2 inhibitors)

The diabetes drug semaglutide reduces infarct size, inflammation, and apoptosis, and normalizes neurogenesis in a rat model of stroke

Characterization and role of glucagon-like peptide 1 receptor in the lacrimal gland: novel insights into diabetic dry eye pathogenesis

Furthermore, disruptions to global logistics routes, particularly through the Strait of Hormuz, would delay the shipment of temperature-sensitive drug components and finished dosage forms between manufacturing hubs (e.g., China, India, and Europe) and key markets (e.g., the US, EU, and Japan), affecting inventory and pricing